BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/21/2018 10:07:19 AM | Browse: 1042 | Download: 1405
 |
Received |
|
2018-09-19 06:53 |
|
Peer-Review Started |
|
2018-09-19 07:52 |
|
To Make the First Decision |
|
2018-10-17 01:13 |
|
Return for Revision |
|
2018-10-17 05:45 |
|
Revised |
|
2018-10-24 08:25 |
|
Second Decision |
|
2018-11-02 09:14 |
 |
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2018-11-02 16:54 |
|
Articles in Press |
|
2018-11-02 16:54 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2018-12-20 08:31 |
|
Publish the Manuscript Online |
|
2018-12-21 10:07 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2018. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Minireviews |
| Article Title |
Percutaneous ablation for perivascular hepatocellular carcinoma: Refining the current status based on emerging evidence and future perspectives
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Tae Wook Kang, Hyo Keun Lim and Dong Ik Cha |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Nano-Convergence Foundation, the Ministry of Science, ICT and Future Planning (MSIP, South Korea) and the Ministry of Trade, Industry and Energy (MOTIE, South Korea) |
R201603110 |
|
| Corresponding Author |
Hyo Keun Lim, MD, PhD, Professor, Department of Radiology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Irwon-ro 81, Gangnam-gu, Seoul 135-710, South Korea. rfalim@skku.edu |
| Key Words |
Hepatocellular carcinoma; Perivascular; Radiofrequency ablation; Liver; Cryoablation; Microwave ablation; Irreversible electroporation |
| Core Tip |
Recently safety concerns have been raised regarding the risks of radiofrequency (RF) ablation for perivascular hepatocellular carcinomas (HCCs), due to the risks of ischemic complications and intravascular tumor spread during treatment. To overcome these potential risks, a modified RF ablation technique, cryoablation, combined treatment with transarterial chemoembolization, or microwave ablation could be problem-solving tools for the treatment of perivascular HCCs. However, the effectiveness of these techniques should be validated with further prospective studies due to the lack of current evidence. |
| Publish Date |
2018-12-21 10:07 |
| Citation |
Kang TW, Lim HK, Cha DI. Percutaneous ablation for perivascular hepatocellular carcinoma: Refining the current status based on emerging evidence and future perspectives. World J Gastroenterol 2018; 24(47): 5331-5337 |
| URL |
https://www.wjgnet.com/1007-9327/full/v24/i47/5331.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v24.i47.5331 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
